Copper containing intra-uterine devices versus depot progestogens for contraception

被引:9
作者
Hofmeyr, G. Justus [1 ]
Singata, Mandisa [2 ]
Lawrie, Theresa A. [2 ]
机构
[1] Univ Ft Hare, Univ Witwatersrand, Dept Obstet & Gynaecol, Eastern Cape Dept Hlth, ZA-5200 E London, Eastern Cape, South Africa
[2] Univ Ft Hare, Univ Witwatersrand, Effect Care Res Unit, ZA-5200 E London, Eastern Cape, South Africa
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2010年 / 06期
关键词
MENSTRUAL BLOOD-LOSS; HORMONAL CONTRACEPTION; ORAL-CONTRACEPTIVES; NULLIPAROUS WOMEN; RISK-FACTORS; IUD; IUCD; HIV; INFECTION; DISEASE;
D O I
10.1002/14651858.CD007043.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Highly effective contraception is essential to reduce unintended pregnancies and the effect these have on individuals, society and public health resources. Intrauterine devices (IUDs) and depot progestogens are two commonly used long-acting, reversible contraceptive methods with different risk and benefit profiles. Objectives To compare the contraceptive and non-contraceptive benefits and risks of using the copper-containing IUD versus depot progestogens for contraception. Search strategy In June 2009 we searched the Cochrane Pregnancy and Childbirth Group Trials Register, the Cochrane Central Register of Controlled Trials, Pubmed, Popline, Clinical Trials.gov, the Current Controlled Trials metaRegister, EMBASE and LILACS, and contacted study authors. Selection criteria Randomized trials comparing women using copper-containing IUDs with women using depot progestogens. Data collection and analysis We assessed eligibility and trialw quality, extracted and double-entered data. Main results Two studies were included in the review. In the one study in HIV infected women, the IUD was compared with depot progestogen or the oral contraceptive, according to the women's choice. As the majority of women chose depot progestogen, we have included this study in the review, within a mixed hormonal contraception sub-group. Overall, the copper IUD was more effective than depot progestogens/hormonal contraception at preventing pregnancy (risk ratio (RR) 0.45; 95% confidence interval (CI) 0.24 to 0.84). HIV disease progression was reduced in the IUD group (RR 0.58; 95% CI 0.39 to 0.87). There was no significant difference in pelvic inflammatory disease rates between the two groups. Discontinuation of the allocated method was less frequent with the IUD in one study, and less frequent with hormonal contraception in the other study (in which women were allowed to switch between various hormonal methods). Authors' conclusions In the populations studied, the IUD was more effective than hormonal contraception with respect to pregnancy prevention. High quality research is urgently needed to compare the effects, if any, of these two commonly used contraception methods on HIV acquisition/seroconversion and HIV/AIDS disease progression.
引用
收藏
页数:19
相关论文
共 59 条
  • [1] All Party Parliamentary Group on Population Development and Reproductive Health, 2007, Return of the Population Growth Factor: Its Impact on the Millennium Development Goals
  • [2] Risk factors for ectopic pregnancy in women with symptomatic first-trimester pregnancies
    Barnhart, Kurt T.
    Sammel, Mary D.
    Gracia, Clarisa R.
    Chittams, Jesse
    Hummel, Amy C.
    Shaunik, Alka
    [J]. FERTILITY AND STERILITY, 2006, 86 (01) : 36 - 43
  • [3] Constrained contraceptive choice: IUD prevalence in Uzbekistan
    Barrett, Jennifer
    Buckley, Cynthia
    [J]. INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 2007, 33 (02): : 50 - 57
  • [4] Contraception for the older woman: an update
    Bhathena, R. K.
    Guillebaud, J.
    [J]. CLIMACTERIC, 2006, 9 (04) : 264 - 276
  • [5] RANDOMIZED COMPARATIVE-STUDY IN 217 WOMEN OF 3 DISPOSABLE PLASTIC IUCD THREAD RETRIEVERS
    BOUNDS, W
    HUTT, S
    KUBBA, A
    COOPER, K
    GUILLEBAUD, J
    NEWMAN, GB
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (11): : 915 - 919
  • [6] Public health - Return of the population growth factor
    Campbell, Martha
    Cleland, John
    Ezeh, Alex
    Prata, Ndola
    [J]. SCIENCE, 2007, 315 (5818) : 1501 - 1502
  • [7] Intrauterine device use in a high-risk population: experience from an urban university clinic
    Campbell, Samuel J.
    Cropsey, Karen L.
    Matthews, Catherine A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (02) : 193.e1 - 193.e7
  • [8] Neoplasia with use of intrauterine devices
    Curtis, Kathryn M.
    Marchbanks, Polly A.
    Peterson, Herbert B.
    [J]. CONTRACEPTION, 2007, 75 (06) : S60 - S69
  • [9] Depot medroxyprogesterone versus Norethisterone oenanthate for long-acting progestogenic contraception
    Draper, B. H.
    Morroni, C.
    Smit, J.
    Beksinska, M.
    Hapgood, J.
    Van der Merwe, L.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03):
  • [10] ELHEFNAWY AS, INT UROGYNECOLOGY J